CAI
CAI
NASDAQ · Biotechnology

Caris Life Sciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$22.74
+2.74 (+13.70%)
As of Aug 8, 1:21 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +36.0% upside
Low Target $20.23
Average Target $30.92
High Target $48.05
Current Price $22.74
Current
$22.74
Target
$30.92
$20.23 $30.92 avg $48.05
Scenario Analysis
Bear Case
$20.23
-11.0%
Low target
Base Case
$30.92
+36.0%
Avg target
Bull Case
$48.05
+111.3%
High target
Risk/Reward
10.1x
Highly favorable
Price in Context
52-Week High
$42.50
-46.5% from high
52-Week Low
$14.19
+60.3% from low
50-Day SMA
$25.57
-11.1% vs SMA
RSI (14)
21.6
Oversold
Target vs 52W High
$30.92
-27.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%